Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
Mechanisms of aluminium neurotoxicity in oxidative stress-induced ... Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
INTRODUCTION Coble 1987). Transdermal absorption of only 0.012% has been reported after a one-time underarm application of 26 Al chlorhydrate (Flarend et al. 2001) while a case report showed that transdermal uptake of aluminium may also be important (Guillard et al. 2004). Distribution of aluminium in the body 60 Once absorbed into the bloodstream, aluminium circulates bound to various plasma proteins: 93% is bound to transferrin, 6% to citrate and the remaining to hydroxide and phosphate (Harris et al. 2003). The metal is distributed unequally to all tissues within the body throughout normal and aluminium-intoxicated individuals (Alfrey et al. 1980, Di Paolo et al. 1997), and aluminium-treated experimental animals (Greger and Sutherland 1997). The highest levels of aluminium in mammalian tissues are found in the skeleton and lungs, approximately 50% and 25% of the 30 to 50 mg aluminium body burden in the healthy human subject (Alfrey 1984, Ganrot 1986, ATSDR 1999). Aluminium also accumulates in human brain, skin, lower gastrointestinal tract, lymph nodes, adrenals, and parathyroid glands (Tipton and Cook 1963, Hamilton et al. 1973, Cann et al. 1979, Alfrey 1980). Aluminium accumulation in different target organs varies with the aluminium salt administered, species studied and route used, dose and duration of exposure (Ding and Zhu 1997, Yokel and McNamara 1988), but also with age, kidney function, disease status, and dietary compounds (Greger 1993). The human brain contains lower levels of aluminium when compared to other organs (Walker et al. 1994, Andrási et al. 2005, Yokel and McNamara 2001). In the case of dialysis encephalopathy, this concentration may aument drastically (Alfrey et al. 1976).
Excretion INTRODUCTION As insoluble aluminium hydroxyl coumpounds are formed at neutral pH most of the dietary aluminium is excreted in the faeces without ever being absorbed. If renal functions are not compromised approximately 95% of the absorbed aluminium is quickly excreted in the urine by kidneys, presumably as aluminium citrate. Biliary system accounts for less than 2% of total aluminium elimination (Kovalchik et al. 1978, Priest et al. 1995, Yokel et al. 1996). Decreased renal functionality increases the risk of aluminium accumulation and toxicity (Greger and Sutherland 2007). Indeed, dialysis encephalopathy syndrome (DES) was developed by renal-impaired people who received aluminium in dialysis fluids or parenterally (Alfrey et al. 1976). Elimination rate Aluminium accumulation is not only due to impaired renal functions or exposure to high quantities of aluminium but also occurs physiologically with aging (McDermott et al. 1979). Aluminium contents of brain, serum, lungs, blood, liver, kidneys, and bone have been demonstrated to increase with age (Markesbery et al. 1984, Zapatero et al. 1995, Greger and Sutherland 1997, Shimizu et al. 1994, U. S. Public Health Service 1992, Stitch 1957, Tipton and Shafer 1964, Roider and Drasch 1999, Markesbery et al. 1981) and younger individuals absorbe less aluminium than older people. Actually, it has been estimated that aluminium deposits in the brain at a rate of 6 μg per year of life (Edwardson 1991). This increasing body burden with age in the brain may be produced by a slow, or no, elimination of aluminium coupled to a continued exposure to the metal and a decreased ability to remove the metal from the brain with age. Different aluminium half-lives (t½) have been reported suggesting that there is more than one compartment of aluminium storage from which the metal is slowly eliminated (Wilhelm et al. 1990, Ljunggren et al. 1991, Priest et al. 1995). The t½ of aluminium elimination positively correlates with the duration of the exposure as longer t½ were observed when the duration of sampling after exposure was increased. Bone stores about 58% of the human aluminium body burden and its aluminium clearance is more rapid than from brain, which is logical regarding to bone turnover and lack of neuron turnover. 61
- Page 33 and 34: Table 1: Differential diagnostic in
- Page 35 and 36: INTRODUCTION Table 3: National Inst
- Page 37 and 38: Figure 4: Dopamine catabolism (Mén
- Page 39 and 40: The basal ganglia INTRODUCTION The
- Page 41 and 42: The death of SNpc DAergic neurons I
- Page 43 and 44: INTRODUCTION the dorsomedial part o
- Page 45 and 46: INTRODUCTION characterized as are l
- Page 47 and 48: INTRODUCTION (Olanow et al. 2004).
- Page 49 and 50: Etiology and pathogenesis of PD INT
- Page 51 and 52: Ageing INTRODUCTION Ageing remains
- Page 53 and 54: INTRODUCTION The finding of MPTP to
- Page 55 and 56: INTRODUCTION may clarify why many n
- Page 57 and 58: Misfolding and aggregation of prote
- Page 59 and 60: INTRODUCTION (E3) (Figure 18A). Los
- Page 61 and 62: INTRODUCTION in connection with Par
- Page 63 and 64: INTRODUCTION Oxidative damage happe
- Page 65 and 66: DA metabolism as a source of ROS IN
- Page 67 and 68: Contribution of oxidative and nitro
- Page 69 and 70: Excitotoxicity INTRODUCTION Glutama
- Page 71 and 72: INTRODUCTION al. 1996, Cicchetti et
- Page 73 and 74: Experimental models of PD INTRODUCT
- Page 75 and 76: INTRODUCTION induce selective DAerg
- Page 77 and 78: ALUMINIUM General features INTRODUC
- Page 79 and 80: INTRODUCTION Varying amounts of alu
- Page 81 and 82: INTRODUCTION and antiperspirants co
- Page 83: INTRODUCTION approximately 3% of al
- Page 87 and 88: INTRODUCTION 3.5 mg may be increase
- Page 89 and 90: INTRODUCTION Oteiza 1999), non-iron
- Page 91 and 92: Aluminium as a cell membrane menace
- Page 93 and 94: INTRODUCTION mobilization of Ca 2+
- Page 95: Aluminium impairs neurotransmission
- Page 99 and 100: AIMS OF THE PRESENT THESIS The main
- Page 101: OBJETIVOS
- Page 104 and 105: OBJETIVOS 3) Evaluar de forma preci
- Page 107: CHAPTER 1 Time-course of brain oxid
- Page 110 and 111: CHAPTER 1 INTRODUCTION 86 6-OHDA (2
- Page 112 and 113: CHAPTER 1 MATERIALS AND METHODS Che
- Page 114 and 115: CHAPTER 1 followed by centrifugatio
- Page 116 and 117: CHAPTER 1 RESULTS Effects of 6-OHDA
- Page 118 and 119: CHAPTER 1 DISCUSSION 94 As shown by
- Page 120 and 121: CHAPTER 1 strategies or to study th
- Page 122 and 123: CHAPTER 1 Fig. 2 Changes in PCC in
- Page 125: CHAPTER 2
- Page 129 and 130: ABSTRACT CHAPTER 2 In the present w
- Page 131 and 132: MATERIALS AND METHODS Chemicals CHA
- Page 133 and 134: CHAPTER 2 atomization used were 1,5
Excretion<br />
INTRODUCTION<br />
As <strong>in</strong>soluble <strong>alum<strong>in</strong>ium</strong> hydroxyl coumpounds are formed at neutral pH most <strong>of</strong><br />
the dietary <strong>alum<strong>in</strong>ium</strong> is excreted <strong>in</strong> the faeces without ever be<strong>in</strong>g absorbed. If renal<br />
functions are not compromised approximately 95% <strong>of</strong> the absorbed <strong>alum<strong>in</strong>ium</strong> is<br />
quickly excreted <strong>in</strong> the ur<strong>in</strong>e by kidneys, presumably as <strong>alum<strong>in</strong>ium</strong> citrate. Biliary<br />
system accounts for less than 2% <strong>of</strong> total <strong>alum<strong>in</strong>ium</strong> elim<strong>in</strong>ation (Kovalchik et al. 1978,<br />
Priest et al. 1995, Yokel et al. 1996). Decreased renal functionality <strong>in</strong>creases the risk <strong>of</strong><br />
<strong>alum<strong>in</strong>ium</strong> accumulation and toxicity (Greger and Sutherland 2007). Indeed, dialysis<br />
encephalopathy syndrome (DES) was developed by renal-impaired people who received<br />
<strong>alum<strong>in</strong>ium</strong> <strong>in</strong> dialysis fluids or parenterally (Alfrey et al. 1976).<br />
Elim<strong>in</strong>ation rate<br />
Alum<strong>in</strong>ium accumulation is not only due to impaired renal functions or exposure<br />
to high quantities <strong>of</strong> <strong>alum<strong>in</strong>ium</strong> but also occurs physiologically with ag<strong>in</strong>g (McDermott<br />
et al. 1979). Alum<strong>in</strong>ium contents <strong>of</strong> bra<strong>in</strong>, serum, lungs, blood, liver, kidneys, and bone<br />
have been demonstrated to <strong>in</strong>crease with age (Markesbery et al. 1984, Zapatero et al.<br />
1995, Greger and Sutherland 1997, Shimizu et al. 1994, U. S. Public Health Service<br />
1992, Stitch 1957, Tipton and Shafer 1964, Roider and Drasch 1999, Markesbery et al.<br />
1981) and younger <strong>in</strong>dividuals absorbe less <strong>alum<strong>in</strong>ium</strong> than older people. Actually, it<br />
has been estimated that <strong>alum<strong>in</strong>ium</strong> deposits <strong>in</strong> the bra<strong>in</strong> at a rate <strong>of</strong> 6 μg per year <strong>of</strong> life<br />
(Edwardson 1991). This <strong>in</strong>creas<strong>in</strong>g body burden with age <strong>in</strong> the bra<strong>in</strong> may be produced<br />
by a slow, or no, elim<strong>in</strong>ation <strong>of</strong> <strong>alum<strong>in</strong>ium</strong> coupled to a cont<strong>in</strong>ued exposure to the metal<br />
and a decreased ability to remove the metal from the bra<strong>in</strong> with age. Different<br />
<strong>alum<strong>in</strong>ium</strong> half-lives (t½) have been reported suggest<strong>in</strong>g that there is more than one<br />
compartment <strong>of</strong> <strong>alum<strong>in</strong>ium</strong> storage from which the metal is slowly elim<strong>in</strong>ated (Wilhelm<br />
et al. 1990, Ljunggren et al. 1991, Priest et al. 1995). The t½ <strong>of</strong> <strong>alum<strong>in</strong>ium</strong> elim<strong>in</strong>ation<br />
positively correlates with the duration <strong>of</strong> the exposure as longer t½ were observed when<br />
the duration <strong>of</strong> sampl<strong>in</strong>g after exposure was <strong>in</strong>creased. Bone stores about 58% <strong>of</strong> the<br />
human <strong>alum<strong>in</strong>ium</strong> body burden and its <strong>alum<strong>in</strong>ium</strong> clearance is more rapid than from<br />
bra<strong>in</strong>, which is logical regard<strong>in</strong>g to bone turnover and lack <strong>of</strong> neuron turnover.<br />
61